Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma
Conditions: Clinical Stage I Esophageal Adenocarcinoma AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Esophageal Adenocarcinoma AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Esophageal Adenocarcinoma AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Interventions: Procedure: Biospecimen Collection; Procedure: Computed Tomography; Procedure: Endoscopic Ultrasound; Procedure: Esophagogastroduodenoscopy; Drug: Fluorouracil; Radiation: Hypofractionated Radiation Therapy; Drug: Leucovorin Calcium; Drug: Ox...
Source: ClinicalTrials.gov - October 12, 2023 Category: Research Source Type: clinical trials
Ketamine-assisted Therapy for Patients With Pancreatic Ductal Adenocarcinoma
Conditions: Pancreatic Ductal Adenocarcinoma; Pain, Acute Interventions: Drug: Ketamine; Behavioral: Meaning and Purpose therapy Sponsors: Brian Anderson, MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
The Seven Trial: Exploiting the Unfolded Protein Response
Conditions: Pancreatic Cancer Metastatic; Pancreatic Adenocarcinoma Metastatic Interventions: Drug: Botensilimab; Drug: Balstilimab; Drug: Chloroquine Phosphate; Drug: Celecoxib Sponsors: HonorHealth Research Institute; Translational Genomics Research Institute; University of Arizona; Agenus Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Danish Assessment of Minimal Residual Disease by Liquid Biopsies
Conditions: Colorectal Neoplasms; Colorectal Cancer; Colorectal Adenocarcinoma; Colorectal Cancer Stage I; Colorectal Cancer Stage II; Colorectal Cancer Stage III Sponsors: University of Aarhus; Aarhus University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 11, 2023 Category: Research Source Type: clinical trials
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
Conditions: Barrett Esophagus; Barretts Esophagus With Dysplasia; Barrett ' s Esophagus Without Dysplasia; Esophageal Adenocarcinoma Interventions: Device: Cytosponge Procedure; Diagnostic Test: Endoscopic Assessment Sponsors: Mayo Clinic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma
Conditions: Pancreatic Cancer Interventions: Drug: BNT321 Dose Level 1; Drug: BNT321 Dose Level 2; Drug: mFOLFIRINOX; Drug: BNT321 RP2D Sponsors: BioNTech SE Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 6, 2023 Category: Research Source Type: clinical trials
Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy
Conditions: Colorectal Neoplasms; Colorectal Neoplasms Malignant; Colorectal Neoplasms, Benign; Colorectal Cancer; Colorectal Polyp; Colorectal Adenoma; Colorectal Adenocarcinoma Interventions: Procedure: Robotic right hemicolectomy; Procedure: Laparoscopic right hemicolectomy Sponsors: Jeremy Meyer; University Hospital, Geneva; Spital Biel, Switzerland; H ôpital Fribourgeois Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
Conditions: Ampullary Adenocarcinoma Interventions: Drug: Folfirinox; Drug: Capox Sponsors: Fondazione Poliambulanza Istituto Ospedaliero; Associazione Italiana per la Ricerca sul Cancro Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Conditions: Endometrial Cancer; Endometrial Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: Carboplatin; Drug: Cisplatin; Drug: Paclitaxel Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Para-aortic Lymph Node Metastasis in Resectable Pancreatic Cancer
Conditions: Pancreas Cancer; Pancreas Adenocarcinoma; Lymph Node Metastasis Interventions: Procedure: PALN resection Sponsors: Jon Unosson Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
A Phase II Trial of Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer
Conditions: Endometrial Cancer; Endometrial Adenocarcinoma Interventions: Drug: Cadonilimab; Drug: Carboplatin; Drug: Cisplatin; Drug: Paclitaxel Sponsors: Fujian Cancer Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
Conditions: Prostate Adenocarcinoma; Stage II Prostate Cancer AJCC v8; Stage IIIA Prostate Cancer AJCC v8; Stage IIIB Prostate Cancer AJCC v8 Interventions: Drug: Apalutamide; Procedure: Biospecimen Collection; Procedure: Computed Tomography; Other: Gallium Ga 68 Gozetotide; Radiation: MRI-guided Stereotactic Body Radiation Therapy; Procedure: Multiparametric Magnetic Resonance Imaging; Procedure: Positron Emission Tomography; Other: Questionnaire Administration Sponsors: Jonsson Comprehensive Cancer Center; Janssen Scientific Affairs, LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 4, 2023 Category: Research Source Type: clinical trials
First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer
Conditions: Ovarian Cancer; High Grade Serous Adenocarcinoma of Ovary; High Grade Endometrioid Ovarian Cancer; Primary Peritoneal Cancer; Fallopian-tube Cancer Interventions: Drug: Fluzoparib Capsules; Drug: Bevacizumab Sponsors: Sun Yat-sen University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy
Conditions: Proximal Gastric Adenocarcinoma; Gastrectomy; Anastomosis; Reflux Esophagitis; Postoperative Complications; Surgically-Created Structures Interventions: Procedure: Kamikawa; Procedure: STJI; Procedure: SOFY Sponsors: Changzhi People ' s Hospital Affiliated to Changzhi Medical College Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Durvalumab and Oleclumab in Resectable PDAC
Conditions: Pancreatic Ductal Adenocarcinoma Interventions: Drug: Durvalumab; Drug: Oleclumab Sponsors: University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 29, 2023 Category: Research Source Type: clinical trials
